Dr. Shenoy is Chief of Infection Control for Mass General Brigham healthcare system. In this role, she is responsible for the development and implementation of infection control strategies, policies, and measurement across the Mass General Brigham system. She is an Associate Professor of Medicine at Harvard Medical School and an Infectious Diseases physician at Massachusetts General Hospital, where she cares for patients on the inpatient Infectious Diseases Consult Service. Dr. Shenoy is Medical Director of the Regional Emerging Special Pathogens Treatment Center at MGH, one of thirteen federally-funded centers with expertise in preparedness and response for emerging pathogens.

Dr. Shenoy a voting member of the Healthcare Infection Control Practices Advisory Committee (HICPAC) at the Centers for Disease Control and Prevention (CDC), the federal advisory committee appointed to provide advice and guidance to DHHS and CDC regarding the practice of infection control and strategies for surveillance, prevention, and control of healthcare-associated infections, antimicrobial resistance and related events in United States healthcare settings. She is a fellow of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (SHEA). She is currently Chair of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee.